topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and COVID-19.

 

AAU has issued a statement regarding provisions slashing research funding in the newly released FY26 Presidential Budget Request.
Every $1 spent by the National Institutes of Health in research funding in FY24 generated $2.56 of economic activity, according to a new report by United for Medical Research.
AAU joined APLU, ARL, and COGR to submit a letter to the NIH Office of Science Policy expressing their strong support for NIH's vision for standardizing metadata and PIDs.
This is a legal filing contesting the unlawful and damaging decree by the administration to cap F&A reimbursement rates to a 15% for all NIH research.
AAU, ACE, and APLU have jointly filed suit in U.S. District Court in Massachusetts, along with a number of impacted research university co-plaintiffs, seeking to halt the NIH's proposed cut to life-saving medical research.
This page will be updated regularly to provide new information as it becomes available regarding the AAU-ACE-APLU lawsuit contesting the National Institutes of Health cutting reimbursement rates to 15%.
As lawmakers consider measures related to securing federally funded research data and intellectual property, it is important to understand the current state of play for research security in the country to avoid new requirements that are duplicative, unnecessary, or counterproductive
AAU President Barbara R. Snyder congratulates Dr. Jay Bhattacharya on his selection by President-elect Trump to be director of the National Institutes of Health (NIH) in the upcoming administration.
AAU, APLU, AAMC, and COGR submitted comments in response to a Request for Information from the National Institutes of Health Draft Public Access Policy. The comments highlight the organizations’ support of the goal of “providing public access to scholarly publications resulting from NIH-funded research”.
AAU and APLU submitted joint comments regarding the NIH's proposed new policy within the Intramural Research Program (IRP) to promote access to products stemming from taxpayer-funded inventions. AAU shares concerns stating "the precedent the proposed terms will set for external R&D."